LONDON (dpa-AFX Broker) - U.K. investment bank Barclays downgraded Südzucker to "underweight" from "equal weight" and cut its price target to 12 euros from 15 euros. The new weight-loss drugs pose a structural threat to food ingredient manufacturers, analyst Alex Sloane wrote in an industry report available Thursday. This is because the increasing public debate about health risks from highly processed foods could further weigh on market expectations for their growth prospects. Therefore, he sees the relevant companies increasingly cautious. Südzucker was still little affected by this due to its low US exposure, but as soon as the weight loss products became more common in Europe as well, this could change./gl/edh

Publication of the original study: 18.10.2023 / 16:19 / GMT First disclosure of the original study: 19.10.2023 / 04:10 / GMT

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------